Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03087344 · ClinicalTrials.gov registry record · NA
Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis
A NA study, sponsored by VA Connecticut Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03087344: Completed NA study, sponsored by VA Connecticut Healthcare System.
NCT03087344 is a NA study that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03087344, a NA study, has completed, sponsored by VA Connecticut Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This is a study that will evaluate the utility of measuring liver and spleen stiffness before and after a meal by a non invasive ultrasound based technologies called Fibroscan (Transient elastography) and acoustic radio-frequency impulse (ARFI) in diagnosing or excluding cirrhosis in patients with chronic liver disease who will be getting a liver biopsy.
Interventions
- DEVICE Fibroscan
- DEVICE Fibroscan and Acoustic Radiation Force Impulse
- DEVICE Acoustic Radiation Force Impulse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-10-31 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03087344
The ClinicalTrials.gov registry entry for NCT03087344 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Connecticut Healthcare System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Fibroscan is the first listed.
NCT03087344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03087344 about?
NCT03087344 is a clinical study titled "Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis". This is a study that will evaluate the utility of measuring liver and spleen stiffness before and after a meal by a non invasive ultrasound based technologies called Fibroscan (Transient elastography) and acoustic radio-frequency impulse (ARFI) in diagnosing or excluding cirrhosis in patients with c...
What is the current status of trial NCT03087344?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-10-31. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT03087344?
The interventions under investigation include: Fibroscan (DEVICE), Fibroscan and Acoustic Radiation Force Impulse (DEVICE), Acoustic Radiation Force Impulse (DEVICE).
Who is sponsoring clinical trial NCT03087344?
This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.